Lead. Live. Boldly.
Lead. Live. Boldly.
Patient Impact
Live boldly
Lead. Live. Boldly.
Therapeutic Areas
We are committed to developing high-impact therapies that enable people with complex brain disorders to live life more fully, brightly, and boldly.
Developing new options for underserved brain disorders
Brain disorders are complex conditions that can place a significant burden on people living with them and those they love. They can make it harder to connect with others, be fully present, and pursue life’s possibilities.
Although advances in medicine have made a meaningful difference, there are still important gaps in treatment. Current options may not address the multi-dimensional range of symptoms patients experience, and some may cause side effects that make it difficult to stay on treatment. Patients deserve better options.
LB is assessing the potential of LB-102 to provide a differentiated option for patients with a broad range of neuropsychiatric disorders. LB-102 is an investigational medicine being evaluated for schizophrenia and bipolar depression, as well as an adjunctive treatment for major depressive disorder.
Lead. Live. Boldly.
Schizophrenia
A complex brain disorder that can affect how a person thinks, feels, and experiences the world. Symptoms can occur in multiple domains, including what are called positive symptoms, negative symptoms, and cognitive symptoms.
Positive symptoms
Symptoms that affect a person’s perception of reality, such as hallucinations, delusions or disorganized behavior.
Negative symptoms
A reduction in emotional expression, motivation, pleasure, joy or social engagement.
Cognitive symptoms
Can include difficulties with memory, attention, executive function or processing information.
Bipolar depression
Depressive episodes associated with bipolar disorder can affect mood, energy, thinking, motivation, and the inability to feel pleasure or joy.
experience cognitive deficits or the inability to feel pleasure
Adjunctive treatment of major depressive disorder
Depression can affect mood, motivation, cognition, and relationships, cause loss of interest or inability to feel pleasure or joy, and may impact other aspects of daily life.
experience cognitive deficits or the inability to feel pleasure
We are currently conducting clinical trials in schizophrenia and bipolar depression, and plan to start a trial for the adjunctive treatment of major depressive disorder in early 2027.